Two Birds with One Stone: Targeting METTL3 Ameliorates Doxorubicin-Induced Endothelial Premature Senescence and Atherosclerosis While Potentiating Its Antitumor Efficacy
{{output}}
Emerging evidence suggests that cancer survivors who have undergone anthracycline therapy frequently experience late-onset atherosclerosis. However, the mechanisms underlying this phenomenon and potential preventive strategies remain largely unexplored. In thi... ...
